| Literature DB >> 31057656 |
I-Lin Wang1, Chien-Yu Hsiao2,3,4, Yu-Heng Li1, Fan-Bo Meng5, Chi-Chang Huang6, Yi-Ming Chen1.
Abstract
PURPOSE: To verify the beneficial effects of Nanobubbles water curcumin extract (NCE) supplementation on health promotion and to demonstrate the application of NCE in reducing the risk of musculoskeletal injury.Entities:
Year: 2019 PMID: 31057656 PMCID: PMC6463623 DOI: 10.1155/2019/8647587
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Schematic of the study design on drop jumps (DJs). Subjects had their hands on their waist and performed the DJs by stepping off a raised platform with their dominant leg sticking out from the platform. The body leans forward naturally to drop onto 2 force plates with each foot on separate plates. They were instructed to jump up from the ground with maximum effort after the first landing.
Effect of supplementation on the biochemical serum profile levels during posttest assessment.
| Parameter | Placebo | NCE |
|
|---|---|---|---|
| AST (U/L) | 16.4 ± 0.4 | 15.6 ± 0.3 | 0.1590 |
| ALT (U/L) | 9.5 ± 0.3 | 6.1 ± 0.5 | 0.0002 |
| ALP (U/L) | 89.4 ± 5.3 | 63.8 ± 2.3 | 0.0013 |
| LDH (U/L) | 176.4 ± 4.07 | 176.4 ± 4.01 | 0.9991 |
| CK (U/L) | 73.6 ± 6.5 | 63.7 ± 3.6 | 0.2136 |
| Albumin (g/L) | 45.6 ± 0.2 | 45.7 ± 0.3 | 0.6469 |
| TP (g/L) | 74.5 ± 0.8 | 74.9 ± 0.8 | 0.7461 |
| BUN (mmol/L) | 13.1 ± 0.2 | 12.4 ± 0.4 | 0.1253 |
| UA (mmol/L) | 4.8 ± 0.1 | 4.9 ± 0.1 | 0.3051 |
| Glucose (mg/dL) | 77.6 ± 1.8 | 78.4 ± 1.8 | 0.7744 |
| TC (mg/dL) | 164± 6 | 153 ± 7 | 0.2411 |
| TG (mg/dL) | 82 ± 4 | 56 ± 4 | 0.0006 |
| HDL (mg/dL) | 48 ± 1 | 57 ± 2 | 0.0017 |
| LDL (mg/dL) | 105 ± 10 | 86 ± 6 | 0.1450 |
Data are mean ± SEM and n = 6 subjects/group. The asterisk (∗) in the same row indicates a significant difference at p<0.05 by One-Way ANOVA. AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; LDH: lactic dehydrogenase; CK: creatine kinase; TP: total protein; BUN: blood urea nitrogen; UA: uric acid; TC: total cholesterol; TG: triglycerides; HDL: high-density lipoprotein; LDL: low-density lipoprotein
General characteristics of the body composition.
| Characteristic | Treatment | Pre-test | Post-test |
| ||
|---|---|---|---|---|---|---|
| Main effect | Main effect | Interaction | ||||
| Weight (kg) | Placebo | 57.1 ± 5.1 | 56.8 ± 5.2 | 0.8554 | 0.9262 | 0.9785 |
| NCE | 56.5 ± 7.6 | 56.4 ± 8.5 | ||||
|
| ||||||
| BMI (kg/m2) | Placebo | 20.7 ± 2.5 | 20.6 ± 2.5 | 0.9602 | 0.9602 | 0.9829 |
| NCE | 20.8 ± 2.9 | 56.7 ± 3.3 | ||||
|
| ||||||
| BMR (kcal/day) | Placebo | 1265 ± 121 | 1261 ± 97 | 0.5452 | 0.9304 | 0.9944 |
| NCE | 1237 ± 112 | 1232 ± 129 | ||||
|
| ||||||
| FFM (kg) | Placebo | 38.8 ± 3.6 | 38.5 ± 3.0 | 0.3989 | 0.8706 | 0.9567 |
| NCE | 37.6 ± 3.2 | 37.4 ± 3.6 | ||||
|
| ||||||
| Fat Mass (%) | Placebo | 26.7 ± 2.6 | 26.5 ± 2.8 | 0.6386 | 0.9374 | 0.9922 |
| NCE | 27.5 ± 5.2 | 27.4 ± 5.1 | ||||
|
| ||||||
| Water content (%) | Placebo | 50.2 ± 0.9 | 50.1 ± 0.9 | 0.5213 | 0.9067 | 0.9533 |
| NCE | 49.8 ± 1.8 | 49.7 ± 1.7 | ||||
|
| ||||||
| Bone salts (kg) | Placebo | 2.98 ± 0.53 | 3.07 ± 0.33 | 0.4771 | 0.8116 | 0.8116 |
| NCE | 3.15 ± 0.46 | 3.15 ± 0.46 | ||||
The main effect of supplementation (Sup) refers to the NCE and placebo treatment and the main effect of time refers to the two-time point assessments (pre-test, post-test). Data are presented as the mean ± SEM for n=6 in each group. A two-way ANOVA was used and a p value <0.05 was considered significantly different. The post-hoc test was performed by a repeated Student's t-test between groups at the same time point and significance (∗) was set to an alpha level of 0.05.
Effect of NCE supplementation on drop jumps (DJs) with kinetic and kinematic data.
| Characteristic | Treatment | Pre-test | Post-test |
| ||
|---|---|---|---|---|---|---|
| Main effect | Main effect | Interaction | ||||
| Jump High (cm) | Placebo | 18.6 ± 1.46 | 19.0 ± 0.62 | 0.2571 | 0.1613 | 0.2342 |
| NCE | 18.6 ± 1.97 | 22.7 ± 1.72 | ||||
|
| ||||||
| Jump High (cm) | Placebo | 19.3 ± 0.92 | 19.3 ±0.84 | 0.4860 | 0.4095 | 0.4068 |
| NCE | 19.1 ± 1.73 | 21.5 ± 1.94 | ||||
|
| ||||||
| Jump High (cm) | Placebo | 17.7 ± 1.11 | 18.1 ± 0.8 | 0.1191 | 0.3242 | 0.4871 |
| NCE | 19.0 ± 1.83 | 21.5 ± 1.68 | ||||
|
| ||||||
| RSI (cm/s) | Placebo | 49.0 ± 3.27 | 44.8 ± 5.15 | 0.0895 | 0.2911 | 0.8004 |
| NCE | 41.2 ± 6.51 | 34.4 ± 4.87 | ||||
|
| ||||||
| RSI (cm/s) | Placebo | 51.1 ± 2.53 | 43.8 ± 5.67 | 0.1604 | 0.5553 | 0.3527 |
| NCE | 39.8 ± 5.7 | 41.4 ± 4.23 | ||||
|
| ||||||
| RSI (cm/s) | Placebo | 47.0 ± 3.59 | 40.1 ± 4.74 | 0.4327 | 0.5115 | 0.3488 |
| NCE | 39.5 ± 4.35 | 40.8 ± 4.2 | ||||
|
| ||||||
| Contact Time (ms) | Placebo | 0.38 ± 0.02 | 0.45 ± 0.05 | 0.0799 | 0.1283 | 0.3224 |
| NCE | 0.48 ± 0.05 | 0.80 ± 0.23 | ||||
|
| ||||||
| Contact Time (ms) | Placebo | 0.38 ± 0.03 | 0.47 ± 0.05 | 0.0379 | 0.1238 | 0.4630 |
| NCE | 0.50 ± 0.03 | 0.53 ± 0.03 | ||||
|
| ||||||
| Contact Time (ms) | Placebo | 0.39 ± 0.04 | 0.48 ± 0.05 | 0.0600 | 0.1112 | 0.5939 |
| NCE | 0.49 ± 0.04 | 0.54 ± 0.03 | ||||
|
| ||||||
| PVGRF (BW) | Placebo | 3.1 ± 0.51 | 2.6 ± 0.29 | 0.2849 | 0.1383 | 0.8394 |
| NCE | 2.8 ± 0.33 | 2.2 ± 0.07 | ||||
|
| ||||||
| PVGRF (BW) | Placebo | 3.7 ± 0.95 | 2.7 ± 0.29 | 0.5291 | 0.1338 | 0.6413 |
| NCE | 3.1 ± 0.35 | 2.6 ± 0.2 | ||||
|
| ||||||
| PVGRF (BW) | Placebo | 4.2 ± 0.65 | 3.2 ± 0.22 | 0.4605 | 0.0662 | 0.6376 |
| NCE | 3.7 ± 0.42 | 3.1 ± 0.28 | ||||
(1) The posttest was assessed after 4 weeks of supplementation.
(2) The main effect of supplementation (sup) refers to the NCE and placebo treatment and the main effect of time is the distance recorded at 2 points (pre- and post-). Data are presented as the mean ± SEM for n=6 in each group. Statistical analysis was using a Two-Way ANOVA. A p value <0.05 was considered significantly different. The post-hoc test was performed by repeated Student's t-test between groups at the same time point and significance (∗) set at an alpha level of 0.05. Drop jumps high (DJH); reactive strength index (RSI); peak vertical ground reaction force (PVGRF).
Figure 2Effect of 4-week-NCE supplementation on serum levels of (a) lactate, (b) ammonia, (c) creatine kinase (CK), and (d) glucose after an acute exercise challenge. Subjects consumed either NCE or placebo for 4 weeks and, one hour following the last administration, a 15-minute spinning bike test was carried out. Data are expressed as mean ± SEM with six subjects in each group. Significance (∗) was set at p < 0.05 by a One-Way ANOVA.